Milkfood (507621)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹682.5 |
| Market Cap | ₹1,675.57 Cr |
| P/E Ratio | 0 |
| ROCE | 6.24% |
| ROE | -2.7% |
| Dividend Yield | 1.2% |
| Profit Growth | -973.33% |
| Debt/Equity | — |
| Sales Growth | -7.9% |
| 52-Week Range | ₹43.99 — ₹682.5 |
| Sector | Food Products |
| Book Value | ₹75.39 |
Strengths
- Operates in dairy products, a consumer staple category with recurring demand.
- Latest quarter sales of ₹74 Cr shows there is still an existing revenue base, though shrinking.
- ROCE is positive at 6.24%, indicating some pre-leverage earnings power relative to capital employed.
- Dividend yield of 1.20% signals some cash distribution despite the reported loss.
Concerns
- Negative ROE of -2.70% and a latest-quarter net loss of ₹8 Cr mean the company is destroying shareholder value.
- Profit growth of -973.33% and sales growth of -7.90% show worsening operations.
- P/B of 9.05 is extreme for a loss-making company; P/E is meaningless because earnings are negative.
- Piotroski F-score of 3/9 and unavailable debt/equity data point to poor or unverifiable financial health.
AI Analysis
As a value investor, I first ask: what will this business earn over ten years? Milkfood gives me no answer. Price ₹682.50, market cap ₹1,676 Cr, but trailing earnings are negative. The P/E is 0.00 because there is no E. Latest quarter sales ₹74 Cr, net loss of ₹8 Cr, and profit growth -973% means losses are widening, not narrowing. Sales fell -7.9%. This is a deteriorating business, not a temporary blip. The balance sheet offers no support: book value ₹75.39, so I pay 9.05 times book for a company earning -2.70% on equity. That is the opposite of Graham's margin of safety. ROCE 6.24% is far below the return I require and likely below any reasonable cost of capital. Piotroski F-score 3/9 confirms poor financial health. With debt/equity not shown, I cannot even size the leverage risk, so I must assume the worst. The dividend yield 1.20% is small comfort when earnings are negative; dividends may not be sustainable. The 52-week range of ₹43.99 to ₹682.50 tells me the market has gone manic, but my job is to estimate value, not chase momentum. This is a speculative situation, not an investment. Graham would say price is what you pay, value is what you get. Here, price has run far ahead of any value I can see. I would need evidence of a genuine turnaround: stabilised sales, positive quarterly profit, higher ROCE, and a sane price. Until then, Milkfood belongs on the too hard pile. I will not let the stock's rise tempt me into a business with negative earnings and no margin of safety.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer